Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Burlington County Public Health Profile Report

Self-Reported Prostate Cancer Screening: Estimated Percent (Age-adjusted), New Jersey, 2017-2020*

  • Burlington
    22.7%
    95% Confidence Interval (17.6% - 27.9%)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.

How Are We Doing?

In 2020, about 15% of New Jersey men aged 40 and over reported that a doctor, nurse, or other health professional have talked to them about the advantages and disadvantages of the PSA test.

Healthy People Objective C-19:

Increase the proportion of men who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider
U.S. Target: 15.9 percent
State Target: 24.4 percent

Related Indicators

Health Status Outcomes:


Note

Age-adjusted to the U.S. 2000 standard population.  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Self-Reported Prostate Cancer Screening

Definition: The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Numerator: The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Denominator: The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question.

Indicator Profile Report

Percentage of Men Aged 40+ Who Reported a Health Professional Has Talked with them about the Advantages and Disadvantages of the PSA Test (exits this report)

Date Content Last Updated

12/07/2022
The information provided above is from the Department of Health's NJSHAD web site (https://nj.gov/health/shad). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Thu, 28 March 2024 12:55:26 from Department of Health, New Jersey State Health Assessment Data Web site: https://nj.gov/health/shad ".

Content updated: no date